Douglas Rheam, DO
Interventional Cardiology · Haddon Heights, NJNPI 1770909608
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,417 of the $18,881 with a category attached, or 60.5%. It is spread thinly across 40 manufacturers, the largest accounting for just 18.6%. Reporting peaked in 2023 at $7,697 and has fallen 78.3% since, to $1,671 in 2025.
Across 251 payments — averaging $75.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$3K
- Penumbra, Inc.$2K
- Philips North America LLC$2K
- Angiodynamics, Inc.$2K
- Boston Scientific$1K
- plus $5K from 34 others
What the payments were for
- Consulting fees$3382%
- Speaking & faculty fees$1,0005%
- Grants$2,60014%
- Travel & lodging$1,80310%
- Food & beverage$11,41760%
- Education$1241%
- Other$1,6008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $3,516 |
| Abbott | 54 | $3,051 |
| Penumbra, Inc. | 10 | $2,355 |
| Philips North America LLC | 20 | $1,964 |
| Angiodynamics, Inc. | 5 | $1,870 |
| Boston Scientific | 18 | $1,030 |
| Cardiva Medical, Inc. | 17 | $831 |
| Shockwave Medical, Inc | 6 | $473 |
| Biotronik Inc. | 5 | $349 |
| Cordis US CORP. | 1 | $338 |
| CMS Imaging, Inc. | 2 | $282 |
| Amgen | 12 | $278 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $233 |
| Bard Peripheral Vascular, Inc. | 3 | $214 |
| Novartis | 15 | $210 |
| Boehringer Ingelheim | 6 | $161 |
| Inari Medical, Inc. | 3 | $156 |
| Siemens Medical Solutions USA, Inc. | 1 | $154 |
| Abiomed | 2 | $154 |
| Atricure, Inc. | 2 | $147 |
| Cardiovascular Systems Inc. | 3 | $140 |
| Merck | 8 | $118 |
| Saranas, Inc. | 1 | $117 |
| Asahi Intecc USA, Inc. | 1 | $87 |
| Cvrx, Inc. | 3 | $82 |
| Bayer | 4 | $76 |
| Johnson & Johnson | 4 | $66 |
| Tactile Systems Technology Inc | 3 | $63 |
| Inspire Medical Systems, Inc. | 3 | $58 |
| Recor Medical Inc | 1 | $52 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $47 |
| Nipro Medical Corporation | 1 | $41 |
| Scpharmaceuticals Inc. | 2 | $41 |
| AstraZeneca | 2 | $29 |
| Heartflow, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Stryker | 1 | $17 |
| Pfizer | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Medicomp Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,165
- VenaCure 1470 Pro$1,600
- (6554) Periph Vasc Undiv$1,000
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$378
- Resolute$321
- Merlin Connectivity and Remote$272
- Confirm Rx$245
- CoreValve Evolut$243
- (6391) Nexcimer$239
- Cardiva VASCADE 6/7F VCS$213
- Artis icono floor$154
- Allure Quadra RF CRT Pacemaker$147
- Mitra Clip system$146
- Pulsar-18 T3$141
- Impella$141
- Xience Sierra Coronary Stent$133
- AngioVac$129
- AVEIR$129
- Astron; Pulsar; AstronPulsar$124
- PRO-Kinetic Energy$124
How this compares
$18,881 in reported general payments places this provider in the 75th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $34,149 |
| Valsartan | 38 | $1,209 |
| Metoprolol Succinate | 51 | $836 |
| Ranolazine ErRanolazine | 13 | $678 |
| ClopidogrelClopidogrel Bisulfate | 47 | $663 |
| Rosuvastatin Calcium | 23 | $553 |
| Losartan Potassium | 15 | $430 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $409 |
| Atorvastatin Calcium | 42 | $313 |
| Amiodarone Hcl | 11 | $263 |
| Carvedilol | 19 | $195 |
| Amlodipine Besylate | 27 | $132 |
| Cilostazol | 11 | $118 |
| Potassium Chloride | 12 | $114 |
| Metoprolol Tartrate | 23 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $34,14927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Haddon Heights
- Adam LevineHaddon Heights$64K
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.